Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.95 USD | +17.70% |
|
+15.88% | +64.02% |
17/06 | Guggenheim Initiates Q32 Bio at Buy With $100 Price Target | MT |
21/05 | Leerink Partners Starts Q32 Bio With Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.02% | 21Cr | |
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.6TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.59TCr | |
-20.90% | 1.51TCr | |
-46.14% | 1.51TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.39TCr |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Transcript : Homology Medicines, Inc. - Special Call